From pathogen to medicine: HIV-1-derived
β
Melissa Dullaers; Kris Thielemans
π
Article
π
2005
π
John Wiley and Sons
π
English
β 272 KB
Over the years, the unique capacity of dendritic cells (DC) for efficient activation of naive T cells has led to their extensive use in cancer immunotherapy protocols. In order to be able to fulfil their role as antigen-presenting cells, the antigen of interest needs to be efficiently introduced and